Works matching IS 14644096 AND DT 2019 AND VI 124

Results: 192
    1
    2
    3
    4
    5
    6
    7

    Editorial Board.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. iv, doi. 10.1111/bju.14929
    Publication type:
    Article
    8

    Table of Contents.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. i, doi. 10.1111/bju.14930
    Publication type:
    Article
    9
    10
    11
    12
    13

    Journal information.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. v, doi. 10.1111/bju.14445
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Characterising 'bounce‐back' readmissions after radical cystectomy.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. 955, doi. 10.1111/bju.14874
    By:
    • Kirk, Peter S.;
    • Skolarus, Ted A.;
    • Jacobs, Bruce L.;
    • Qin, Yongmei;
    • Li, Benjamin;
    • Sessine, Michael;
    • Liu, Xiang;
    • Zhu, Kevin;
    • Gilbert, Scott M.;
    • Hollenbeck, Brent K.;
    • Urish, Ken;
    • Helm, Jonathan;
    • Lavieri, Mariel S.;
    • Borza, Tudor
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Long‐term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large‐scale population‐based analysis.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. 1006, doi. 10.1111/bju.14841
    By:
    • Mazzone, Elio;
    • Mistretta, Francesco A.;
    • Knipper, Sophie;
    • Palumbo, Carlotta;
    • Tian, Zhe;
    • Pecoraro, Angela;
    • Preisser, Felix;
    • Gallina, Andrea;
    • Shariat, Shahrokh F.;
    • Saad, Fred;
    • Graefen, Markus;
    • Montorsi, Francesco;
    • Briganti, Alberto;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    27

    Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.

    Published in:
    BJU International, 2019, v. 124, n. 6, p. 999, doi. 10.1111/bju.14839
    By:
    • McIntosh, Andrew G.;
    • Parker, Daniel C.;
    • Egleston, Brian L.;
    • Uzzo, Robert G.;
    • Haseebuddin, Mohammed;
    • Joshi, Shreyas S.;
    • Viterbo, Rosalia;
    • Greenberg, Richard E.;
    • Chen, David Y. T.;
    • Smaldone, Marc C.;
    • Kutikov, Alexander
    Publication type:
    Article
    28
    29
    30
    31
    32

    Issue Information.

    Published in:
    BJU International, 2019, v. 124, p. 1, doi. 10.1111/bju.14962
    Publication type:
    Article
    33
    34

    Abstracts.

    Published in:
    BJU International, 2019, v. 124, p. 4, doi. 10.1111/bju.14952
    Publication type:
    Article
    35
    36

    TheraP: a randomized phase 2 trial of <sup>177</sup>Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603).

    Published in:
    BJU International, 2019, v. 124, p. 5, doi. 10.1111/bju.14876
    By:
    • Hofman, Michael S.;
    • Emmett, Louise;
    • Violet, John;
    • Y. Zhang, Alison;
    • Lawrence, Nicola J.;
    • Stockler, Martin;
    • Francis, Roslyn J.;
    • Iravani, Amir;
    • Williams, Scott;
    • Azad, Arun;
    • Martin, Andrew;
    • McJannett, Margaret;
    • Davis, Ian D.
    Publication type:
    Article
    37
    38
    39

    Diagnostic accuracy of <sup>68</sup>Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of <sup>68</sup>Ga‐PSMA PET to mpMRI

    Published in:
    BJU International, 2019, v. 124, p. 42, doi. 10.1111/bju.14794
    By:
    • Scheltema, Matthijs J.;
    • Chang, John I.;
    • Stricker, Phillip D.;
    • Leeuwen, Pim J.;
    • Nguyen, Quoc A.;
    • Ho, Bao;
    • Delprado, Warick;
    • Lee, Jonathan;
    • Thompson, James E.;
    • Cusick, Thomas;
    • Spriensma, Alette S.;
    • Siriwardana, Amila R.;
    • Yuen, Carlo;
    • Kooner, Raji;
    • Hruby, George;
    • O'Neill, Gordon;
    • Emmett, Louise
    Publication type:
    Article
    40

    Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT)‐guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single‐institution experience and review of the published literature

    Published in:
    BJU International, 2019, v. 124, p. 19, doi. 10.1111/bju.14886
    By:
    • Ong, Wee Loon;
    • Koh, Tze Lui;
    • Lim Joon, Daryl;
    • Chao, Michael;
    • Farrugia, Briana;
    • Lau, Eddie;
    • Khoo, Vincent;
    • Lawrentschuk, Nathan;
    • Bolton, Damien;
    • Foroudi, Farshad
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Editorial Board.

    Published in:
    BJU International, 2019, v. 124, n. 5, p. iv, doi. 10.1111/bju.14855
    Publication type:
    Article
    48

    Table of Contents.

    Published in:
    BJU International, 2019, v. 124, n. 5, p. i, doi. 10.1111/bju.14854
    Publication type:
    Article
    49

    BJUI Compass and open access.

    Published in:
    BJU International, 2019, v. 124, n. 5, p. 713, doi. 10.1111/bju.14911
    By:
    • Dasgupta, Prokar;
    • Davis, John W.
    Publication type:
    Article
    50